Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy CEO bought 400 shares at an average $0.10 ($41)
  2. 4 Open-market buy Director bought 100 shares at $0.96 ($96)
  3. 4/A Open-market buy CEO bought 200 shares at an average $2.00 ($400)
  4. 4/A Open-market buy CEO bought 5,700 shares at an average $0.03 ($163)
  5. 4 Open-market buy Ceo bought 200 shares at an average $2.00 ($400)
  6. 4 Open-market buy Ceo bought 5,700 shares at an average $0.00 ($13)
  7. 4 Open-market buy Ceo bought 15,000 shares at an average $0.00 ($46)
  8. 4 Open-market buy Ceo bought 3,000 shares at an average $0.00 ($11)
  9. 4 Open-market buy Ceo bought 2,000 shares at $0.01 ($14)
  10. 4 Open-market buy CEO bought 51,200 shares at an average $0.01 ($269)
  11. 4 Open-market buy CEO bought 10,400 shares at an average $0.01 ($107)
  12. 4 Open-market buy CEO bought 600 shares at an average $0.01 ($6)
  13. 4 Open-market buy CEO bought 700 shares at an average $0.01 ($5)
  14. 4 Open-market buy CEO bought 32,000 shares at an average $0.01 ($288)
  15. 4 Open-market buy CEO bought 114,000 shares at an average $0.01 ($1,113)
  16. 4 Open-market buy CEO bought 119,000 shares at an average $0.01 ($1,226)
  17. 4 Open-market buy CEO bought 55,000 shares at an average $0.01 ($597)
  18. 4 Open-market buy CEO bought 89,500 shares at an average $0.01 ($918)
  19. 4 Open-market buy CEO bought 62,000 shares at an average $0.01 ($698)
  20. 4 Open-market buy CEO bought 96,000 shares at an average $0.01 ($1,186)

Page 1 of 16 · 306 filings